Belite Bio BLTE
NASDAQ BLTE
$166.66 +0.73 (+0.44%)
At close: Sep 29, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Share-based Compensation (2024 - 2025)

Updated

Belite Bio (BLTE) posted Share-based Compensation of $11.71 million for Q4 2025, up 178.6% from $4.21 million a year earlier.

Analysis

Belite Bio (BLTE) Share-based Compensation (2024 - 2025) Analysis & Trends

For FY2025, Belite Bio's Share-based Compensation came in at $38.92 million, up 333.1% from FY2024.

  • Annual Share-based Compensation has increased for three consecutive years, with a five-year compound annual growth rate of 95.5% (FY2020 to FY2025).
  • In prior years, Belite Bio's Share-based Compensation was $8.99 million in FY2024 (+135.1%), $3.82 million in FY2023 (+157.8%), $1.48 million in FY2022 (-3.1%) and $1.53 million in FY2021 (+12.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Belite Bio 6.53 Bn 6.53 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11.71 Mn
Dec 31, 2024 4.21 Mn
API Access

Belite Bio Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BLTE&period=max&api_key=YOUR_API_KEY